Multiple Sclerosis Patient Counseling Tool

A comprehensive guide to talking to patients, this piece explains MS and the variety of treatment options available. The Patient Counseling Tool also highlights the importance of early intervention, so patients understand the benefits of starting therapy early - and staying compliant over the long term.

Enrollment Begins For Study Of MBP8298 In Secondary-Progressive ...
Medical News Today (press release) - UK
in 510 people with secondary-progressive multiple sclerosis. Up to 60 sites nationwide will be enrolling patients by September. This drug is administered ...
See all stories on this topic

NCCN Updates Non-Hodgkin's Lymphoma Guidelines
Business Wire (press release) - San Francisco,CA,USA
For certain patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, alemtuzumab (Campath(r), Genzyme) was added as a first-line therapy ...
See all stories on this topic

Enrollment Begins For Study Of MBP8298 In Secondary-Progressive Multiple Sclerosis
Medical News Today Wed, 20 Jun 2007 1:08 AM PDT
Summary: Enrollment has begun for a study testing the safety and effectiveness of the experimental drug MBP8298 (BioMS Medical Corp.) in 510 people with secondary-progressive multiple sclerosis. Up to 60 sites nationwide will be enrolling patients by September. This drug is administered intravenously (into the vein) every 6 months. [click link for full article]

Gordon Brown Welcomes MS Experts To London
Medical News Today Wed, 20 Jun 2007 1:09 AM PDT
Gordon Brown MP said: "I would like to welcome delegates to the MS Society's Frontiers research conference in London. Multiple sclerosis is a devastating condition and it is vital that the UK plays a lead in promoting high quality research in a bid to improve our understanding of the disease. People with MS, their families and carers greatly value your efforts. [click link for full article]

Facts & Figures On Neurological Diseases In Europe
Medical News Today Wed, 20 Jun 2007 0:06 AM PDT
In 2004 there were about 46 million cases of neurological diseases such as epilepsy, migraines, multiple sclerosis, Parkinson's disease and stroke among the 466 million inhabitants of the EU (excluding the two new members Romania and Bulgaria, but including the non-members Iceland, Norway and Switzerland). [click link for full article]

Possible Target Of Immune Attack In MS And New Therapeutic Approach Identified By National MS Society-Sponsored ...
Medical News Today Wed, 20 Jun 2007 1:08 AM PDT
A new study by National MS Society-supported researchers suggests a small protein (alpha B-crystallin) normally produced by cells to protect against injury may itself be the target of the multiple sclerosis immune attack. Administering the protein to mice with a similar disease countered the effect, opening the door to a potential new therapeutic approach for MS. [click link for full article]

MS Society Chief Executive Tells Britain's Next Prime Minister Gordon Brown Of The Importance Of Supporting UK's Six ...
Medical News Today Wed, 20 Jun 2007 1:09 AM PDT
A partnership of seven charities joined together as part of Carers Week at 11 Downing Street to highlight the lives of carers, including those who care for people with multiple sclerosis (MS), who are often overlooked in society. [click link for full article]

GW's Cannabis-Based Drug Sativex Approved in Canada ; BUSINESS
RedNova Wed, 20 Jun 2007 2:22 AM PDT
By Karen Attwood GW Pharmaceutical's cannabis-based drug has been approved as a treatment for cancer pain in Canada, the company announced yesterday. The under-the-tongue spray Sativex is already on sale in the country as a treatment for multiple sclerosis.

Scientists move closer to human therapeutic cloning
Reuters via Yahoo! News Wed, 20 Jun 2007 5:14 AM PDT
Human therapeutic cloning has moved a step closer after U.S. researchers said they had successfully created embyonic stem cells from monkey embryos.

Positive Results Published On Testosterone For Men With MS
Medical News Today Wed, 20 Jun 2007 1:09 AM PDT
Researchers from the University of California, Los Angeles have published results from a small study, funded by the National MS Society and others, suggesting that one year of treatment with a gel containing the sex hormone testosterone (applied to the skin) in 10 men with relapsing-remitting multipl [click link for full article]

Unproven Goat Serum Treatment Under The Microscope
Medical News Today Wed, 20 Jun 2007 1:09 AM PDT
The Guardian today looks into concerns raised by the MS Society about the promotion and sale of Aimspro - a treatment derived from goat serum that is currently available on a specials licence to people with MS who are prepared to pay for it. [click link for full article]

Stem Cell Bill Passes MS, Activists Attend Event At U.S. Capitol - Stem Cell Bill Moves To President's Desk
Medical News Today Wed, 20 Jun 2007 1:08 AM PDT
The House of Representatives passed the Stem Cell Research Enhancement Act (S. 5) on Thursday, June 7, with a bipartisan vote of 247 to 176. Thank you to the thousands of you who contacted your representatives in Congress recently in support of this issue. Several MS activists participated in an event lauding the passage of the bill in the U.S. Capitol building following the vote. [click link for ...